TGF-β3 mRNA levels were higher in patients with tumors with mutations in the NF1 gene, for all patients pooled (p=0.013) and also in patients diagnosed for the mesenchymal glioblastoma subgroup (p=0.03) (Supplementary Figure 9B). Here, NF1 is linked to glioblastoma.